{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:20:14Z","timestamp":1781184014174,"version":"3.54.1"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T00:00:00Z","timestamp":1355788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0052236","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T17:07:49Z","timestamp":1355850469000},"page":"e52236","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Current Status of Artemisinin-Resistant falciparum Malaria in South Asia: A Randomized Controlled Artesunate Monotherapy Trial in Bangladesh"],"prefix":"10.1371","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct00639873","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Peter","family":"Starzengruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Fuehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasif A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Hofecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Siedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Fally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paktiya","family":"Teja-Isavadharm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashidul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Ringwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Noedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,18]]},"reference":[{"key":"ref1","unstructured":"WHO (2010) Guidelines for the treatment of malaria. Second edition. Geneva, Switzerland: WHO. ISBN: 9789241547925."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"H Noedl","year":"2008","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1086\/657120","article-title":"Artemisinin resistance in cambodia: a clinical trial designed to address an emerging problem in southeast Asia","volume":"51","author":"H Noedl","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMc0900231","article-title":"Artemisinin-resistant malaria in Asia","volume":"361","author":"H Noedl","year":"2009","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in <italic>Plasmodium falciparum<\/italic> malaria","volume":"361","author":"AM Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4269\/ajtmh.2007.76.39","article-title":"Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated <italic>Plasmodium falciparum<\/italic> malaria in Bangladesh","volume":"76","author":"R Haque","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4269\/ajtmh.2006.75.645","article-title":"Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh","volume":"75","author":"K Thriemer","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1086\/653710","article-title":"Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial","volume":"202","author":"K Thriemer","year":"2010","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","article-title":"Spread and evolution of <italic>Plasmodium falciparum<\/italic> drug resistance","volume":"58","author":"T Mita","year":"2009","journal-title":"Parasitol Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.1098876","article-title":"Intercontinental spread of pyrimethamine-resistant malaria","volume":"305","author":"C Roper","year":"2004","journal-title":"Science"},{"key":"ref11","first-page":"277","article-title":"Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia","volume":"89","author":"J Verdrager","year":"1986","journal-title":"J Trop Med Hyg"},{"key":"ref12","unstructured":"WHO (2000) Management of severe malaria. A practical handbook. Second edition. Geneva, Switzerland: WHO. ISBN 92 4 154523 2."},{"key":"ref13","unstructured":"WHO (2003) Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. WHO\/HTM\/RBM\/2003.50. Geneva, Switzerland: WHO."},{"key":"ref14","unstructured":"Snounou G (2001) Genotyping of <italic>Plasmodium<\/italic> spp. In: Doolan DL, eds. Methods in Molecular Medicine. Vol. 72. Malaria Methods and Protocols. 103\u2013116."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4269\/ajtmh.2004.71.711","article-title":"A histidine-rich protein 2-based malaria drug sensitivity assay for field use","volume":"71","author":"H Noedl","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1128\/AAC.49.8.3575-3577.2005","article-title":"Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing","volume":"49","author":"H Noedl","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","unstructured":"Siriyanoda D, Teja-Isavadharm P, Chanarat N, Lim A, Wannaying S, <etal>et al<\/etal>.. (2005) LC\/MC Analysis of artesunate and dihydroartemisinin in plasma following a single step protein precipitation [abstract 344]. In: Program and abstracts of the 54<sup>th<\/sup> annual meeting of the American Society of Tropical Medicine and Hygiene (Washington, DC)."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.pt.2005.06.012","article-title":"Artemisinin resistance: how can we find it?","volume":"21","author":"H Noedl","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-3156.2005.01557.x","article-title":"<italic>In vivo<\/italic> sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003","volume":"11","author":"S Vijaykadga","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molmed.2006.03.005","article-title":"Re-evaluation of how artemisinins work in light of emerging evidence of <italic>in vitro<\/italic> resistance","volume":"2","author":"S Krishna","year":"2006","journal-title":"Trends Mol Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4269\/ajtmh.2003.68.140","article-title":"Drug-resistant malaria in Bangladesh: an <italic>in vitro<\/italic> assessment","volume":"68","author":"H Noedl","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1086\/650301","article-title":"<italic>In vivo<\/italic> parasitological measures of artemisinin susceptibility","volume":"201","author":"K Stepniewska","year":"2010","journal-title":"J Infect Dis"},{"key":"ref23","unstructured":"WHO (2001) The use of antimalarial drugs. Report of a WHO Informal Consultation, WHO\/CDS\/RBM\/2001.33 Geneva, Switzerland: WHO."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0052236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T01:52:53Z","timestamp":1562464373000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0052236"}},"subtitle":[],"editor":[{"given":"Steffen","family":"Borrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,18]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0052236","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,18]]}}}